HTDS - Hard to Treat Diseases (PINK)

[zeroveritas]

In long run it should still climb to $0.05


Any Comment?

I get a lot of flak for "bashing" HTDS.

It's just that after doing a lot of research there seems to be a lot of things that are fishy or just dont add up.

For instance, they say they had all these deals for swine flu drugs that never materialized and their financials released were only a few thousand in profits.

They push out a lot of great PR unfortunately nothing comes of it and to mask it they release PR about something completely different to distract investors from asking questions about their previous deals...

plus after researching mir mara investments I do not want to be involved in any of their stocks... LDSR, MONA and HTDS>

If you research any of the above you will see what i am talking about. The PR never materializing and the mir mara investments.

HTDS was heavily pumped by paid promoters and it is an easy one to get sucked into. I just don't buy the hype.

LLBO gets a lot of negative attention from disgruntled ex-investors who lost money in the stock from reverse splits and dilution. I feel bad for them but after doing my DD i believe dilution and RS are a thing of the past as we get geared up for FDA classification and finally 510k submission and approval.

believe what you want about HTDS but I think a lot of investors are realizing that this company is full of bs and thats why the price has been slowly dropping.... I could be wrong but thats just my take on the situation and you can do what you want with it.

That and the entire biopharm sector in general is in the red lately....

GETA, HEB, LLBO, BIEL etc.. all taking big hits. Hopefully this turns around.

[bdogsdad]

Me too brother

[shockdragon]

From Rain Delay of Google Board:

http://www.pinksheets.com/otciq/ajax...d.pdf?id=25364

[gansta6]

No I haven't herard anything but I picked up another 10000 shares last week so I hope you are right and let everyone know when you do. thanks.

[shockdragon]

Hard to Treat Diseases Inc. (HTDS) Targets an EU Based Stem Cell Research Company for a Merger | Reuters

[johnjohny753]

Hard to Treat Diseases Inc. (HTDS) Targets an EU Based Stem Cell Research Company for a Merger | Reuters

Lets hope for the BEST

[bdogsdad]

Looks like an up day today..

[johnjohny753]

SHENZHEN, China, Nov. 3 /PRNewswire-FirstCall/ - Hard to Treat Diseases (HTDS; Welcome to HTDS Medical) Mellow Hope operating subsidiary is in process of finalizing contract details with Hetero Ltd., Welcome to Hetero Drugs one of the largest pharmaceutical manufacturers in India. This contract has been in the works since March 2009, and its finalization promises solid sales boost for Hard to Treat Diseases.

The contract between secures the supply of raw pharmaceutical material for HTDS' Mellow Hope in the range of about 4 million dollars. The contract completion is in final stages, and the shipments are already scheduled. This contract is bound to strengthen present and future sales of the raising pharmaceutical dragon Mellow Hope of Hard to Treat Diseases (HTDS).




Read More

[stockman]

Novartis to buy 85% of Chinese vaccines producer
TEL AVIV (MarketWatch) -- Novartis AG, /quotes/comstock/13*!nvs/quotes/nls/nvs (NVS 52.13, -0.20, -0.38%) /quotes/comstock/06p!novn (CH:NOVN 53.00, -0.55, -1.03%) the Basel health-care giant, said on Wednesday that it definitively agreed to acquire 85% of the closely held Chinese vaccines company Zhejiang Tianyuan Bio-Pharmaceutical Co. for about $125 million cash.

Novartis to buy 85% of Chinese vaccines producer - MarketWatch

[stockman]

Novartis to Acquire Majority Stake in Hard to Treat Diseases' (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million


TD Ameritrade